Recent advances in multifactorial regulation of vascular calcification

Current Opinion in Lipidology

Volumn 12, Issue 5, 2001, Pages 555-560

  Tintut, Y ^a   Demer, L L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM SENSING RECEPTOR; CELL PROTEIN; LEPTIN; LIPID; MATRIX PROTEIN; OSTEOCALCIN; OSTEOPROTEGERIN; PHOSPHOLIPID; TRANSCRIPTION FACTOR PIT 1;

AGE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; BONE MINERALIZATION; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERLIPIDEMIA; OSTEOPOROSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK FACTOR;

ANIMALS; ARTERIOSCLEROSIS; CALCINOSIS; CALCIUM-BINDING PROTEINS; DIPHOSPHONATES; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LIPID METABOLISM; OSTEOPOROSIS; VASCULAR DISEASES;

EID: 0034779259     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200110000-00012     Document Type: Review

References (49)

1. Vascular calcification: A passive process in need of inhibitors
2. Calcific diseases: A concept
3. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human artherosclerotic plaques
4. Bone morphogenetic protein expression in human atherosclerotic lesions
5. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques
6. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events
7. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality
8. The impact of calcification on the biomechanical stability of atherosclerotic plaques
9. Calcification of the aortic arch: Risk factors and association with coronary heart disease, stroke, and peripheral vascular disease
10. Bone formation and inflammation in cardiac valves
11. Matrix Gla protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells
12. Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2)
13. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells: Potential signaling pathway for vascular calcification
14. Matrix Gla protein is differentially expressed during the deposition of a calcified matrix by vascular pericytes
15. Warfarin-induced artery calcification is accelerated by growth and vitamin D
16. Phosphate regulation of vascular smooth muscle cell calcification
17. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
18. Matrix Gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor
19. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
20. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis
21. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells
22. RANKL and OPG expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis
23. Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
24. Leptin enhances the calcification of vascular cells: Artery wall as a target of leptin
25. Relationship between aortic calcification and atherosclerotic disease in patients with abdominal aortic aneurysm
26. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: A possible explanation for the paradox of arterial calcification in osteoporotic patients
27. Isolation of calcifiable vesicles from aortas of rabbits fed with high cholesterol diets
28. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-l-) mice are ameliorated by enalapril treatment
29. Association between mitral annulus calcification and peripheral arterial atherosclerotic disease
30. Natural history and topographic pattern of progression of coronary calcification in symptomatic patients: An electron-beam CT study
31. Association between calcific aortic stenosis and hypercholesterolemia: Is there a need for a randomized controlled trial of cholesterol-lowering therapy?
32. Prevalence and correlates of coronary calcification in black and white young adults: The coronary artery risk development in young adults (CARDIA) study
33. Lack of association of lipoprotein (a) levels with coronary calcium deposits in asymptomatic postmenopausal women
34. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway
35. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men
36. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: Implications for coronary artery disease screening
37. Vitamin K status and bone mass in women with and without aortic atherosclerosis: A population-based study
38. Progression of aortic calcification is associated with metacarpal bone loss during menopause: A population-based longitudinal study
39. Genetic loci determining bone density in mice with diet-induced atherosclerosis
40. Atherogenic high-fat diet reduces bone mineralization in mice
41. Hyperlipoproteinemia, the Apo-E genotype and bone density
42. HMG-CoA reductase inhibitors and the risk of fractures
43. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
44. Inhibitors of hydroxymethylglutaryl-coenzym A reductase and risk of fracture among older women
45. Oral statins and increased bone mineral density in postmenopausal women
46. Effect of pravastatin on frequency of fracture in the LIPID study
47. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption
48. Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol
49. Natural history of calcium deposits in atherosclerosis progression and regression